上海玉博生物科技有限公司 主要致力于“DQB1*0602;DQA1*0102 excl. Taq (24) Qiagen 101.901-24U”的生产销售。多年的“DQB1*0602;DQA1*0102 excl. Taq (24) Qiagen 101.901-24U”生产与销售的经验,与各行业新老用户建立了稳定的合作关系,我公司经营的产品名称深受广大用
结果发作性睡病患者组DQB1*0602基因频率为40%,与正常对照组9.09%相比较明显增高;未检出DQB1*0401-0402基因,与正常对照组9.09%相比较,经统计学分析,差异有显著性(P<0.05)。结论HLA-DQB1*0602基因为发作性睡病人群的易感基因;HLA-DQB1*0401-0402基因为中国发作性睡病人群的保护基因关键字:发作性睡病;HLA基因...
分别测定其HLA-DQB1*0602状态、低O_2高CO_2(△VE/△PCO_2,L/min/mmHg)反应性和低O_2(△VE/△SaO_2,L/min/%SaO_2)反应性。下丘脑分泌素缺乏的判定是通过检测脑脊液下丘脑分泌素水平(37名患者)或通过检测HLA-DQB1*0602(95%的HLA-DQB1*0602阳性患者伴有脑脊液水平降低)。所有患者和49%的正常对照都...
Background: The human leukocyte antigen (HLA) class II DR2 haplotype (DRB1*1501, DQA1*0102, DQB1*0602) has been associated with multiple sclerosis (MS) in all ethnic groups and very strongly in Caucasians. Aim: To investigate the possible HLA class II (DRB1, DQA1 and DQB1) associations ...
典型猝倒并人类白细胞抗原(HLA)-DQB1 * 0602(+)对发作性睡病患者脑脊液下丘脑分泌素(HCRT)-1降低的预测价值.方法 收集2003年3月至2017年3月在北京大学人民医院和北京大学国际医院睡眠中心就诊的发作性睡病患者共165例,对所有入组患者进行DQB1 * 0602基因及脑脊液HCRT-1测定.依据能否同时满足猝倒并DQB1 *.....
通过比较MSLT、HLA-DQB1*0602等各预测参数在诊断发作性睡病中的差异,从而找出诊断发作性睡病价值相对较高的指标,以指导临床早期发现、早期诊断及早期治疗。方法:收集1型发作性睡病患者共171例和年龄和性别相匹配的正常健康志愿者57例,年龄在19-24岁,以国际睡眠障碍分类第3版作为诊断发作性睡病的金标准。所有参与...
HLA—DRB1 ＊1501和DQB1 ＊0602与新疆哈萨克族HPV感染及食管癌发生的相关性研究
Conclusion: Passive smoking may be a risk factor for narcolepsy in subjects with HLA DQB1*0602. Future studies could help clarify whether passive smoking is an important etiologic component of narcolepsy among genetically susceptible individuals. 展开 关键词: Case-control study Epidemiology HLA-DQ ...
Multiple Sclerosis (MS) is a demyelinating disease associated with the HLA-DR2-related haplotype DRB1*1501, DQB1*0602 in Caucasoids and with DQB1*0602 in DR2-positive Cantonese. However, many MS patients do not have the high-risk HLA-D determinants and alternative genes may contribute to th...
结果伴有猝倒发作的发作性睡病患者组的HLA-DRB1*1501-HLA-DQB1*0602单体型的阳性率为30%(6/18),无典型猝倒发作的发作性睡病患者组的HLA-DRB1*1501-HLA-DQB1*0602单体型的阳性率为29.2%(7/24),正常对照组的HLA-DRB1*1501-HLA-DQB1*0602单体型的阳性率为9%(5/55),猝倒发作的发作性睡病患者组的HLA-DRB1...